A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL FOLLOW-UP TO DETERMINE THE SAFETY AND EFFICACY OF SUBCUTANEOUS DOSES OF R-HUEPO IN AIDS PATIENTS WITH ANEMIA INDUCED BY THEIR DISEASE AND AZT THERAPY: